Alabama
Birmingham; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Birmingham; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Birmingham; Clinical Research Consultants, Inc.
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Birmingham; Global Clinical Trial Link, LLC
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Hueytown; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Huntsville; Medical Affiliated Research Center, Inc.
Osteoarthritis? Rheumatoid Arthritis? Lower Back Pain? Severe Joint Pain? Clinical Research study for Chronic Pain.
Huntsville; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Huntsville; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Huntsville; Tennessee Valley Pain Consultants
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Huntsville; Medical Affiliated Research Center, Inc.
You may not know some pain medications can cause stomach ulcers
Arizona
Casa Grande; Desert Oasis Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Chandler; Radiant Research - Phoenix
Chronic Pain Research
Peoria; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Peoria; Pivotal Research Centers, LLC
Chronic Pain
Phoenix; Redpoint Research
Shoulder Pain
Phoenix; Redpoint Research
Elbow Pain
Phoenix; Hope Research Institute, LLC
Do you suffer from chronic pain?
Tucson; Advanced Clinical Therapeutics LLC
Are you taking ibuprofen, Aleve®, or Advil® every day to manage your chronic arthritis pain, or low back pain?
Arkansas
Sherwood; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
California
Anaheim; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Anaheim; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Bakersfield; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Cypruss; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Duarte; City of Hope
A Compassionate Use Study of Methylnaltrexone in Patients with Opioid-Induced Side Effects
Fountain Valley; Pacific Coast Hematology/Oncology Medical Group, Inc.
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Garden Grove; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Gilroy; Office of Dr. Ronald Yanagihara
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Laguna hills; Therapeutic Research Insitiute of Orange County
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Loma Linda; Center for Pain Management
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Long Beach; Long Beach VA Medical Center
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Menlo Park; Omneuron, Inc.
Treatment of Chronic Pain using Real Time functional fMRI
San Diego; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
San Diego; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
San Diego; San Diego Managed Care Group
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Torrance; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Torrance; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Colorado
Boulder; Alpine Clinical Research Center
Do You Suffer With Chronic Pain Due to Shingles?
Boulder; Alpine Clinical Research Center
Do you suffer with chronic pain due to shingles?
Springs; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Wheat Ridge; Front Range Clinical Research
Do you have to take daily medication for pain?
Connecticut
Torrington; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Florida
Chiefland; Chiefland Medical Center
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Clearwater; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Daytona Beach; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Daytona Beach; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Jacksonville; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Jasonsville; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Jupiter; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Largo; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Miami; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Miami; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Miami; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Ocree; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Ocree; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Pembroke Pines; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Plantation; Gold Voast Research LLC
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Port Orange; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Port Orange; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Tampa; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Tampa; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Tampa; University of Southern Florida
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
West Palm Beach; Palm Beach Research Center
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Weston; Gold Coast Research, LLC
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Zephryhills; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Georgia
Atlanta; PMI Health Research Group
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Decatur; Dekalb Pain Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Macon; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Stockbridge; Center of Hope for Cancer and Blood Disorders
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Idaho
Hayden Lake; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Illinois
Bloomington; Millennium Pain Center Research Department
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Moline; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Rockford; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Kansas
Prarie Village; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Wichita; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Kentucky
Lexington; University of Kentucky Chandler Medical Center
Pain-Free Female Volunteers Needed for Study on Chronic Pain
Louisiana
New Liberia; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
New Liberia; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
New Orleans; Louisiana Research Associates
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Shreveport; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Shreveport; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Maryland
Baltimore; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Baltimore; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Hagerstown; Research Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Hollywood; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Hollywood; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Laurel; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Massachusetts
Boston; Massachusetts General Hospital (MGH)
Pain Responses in Patients with Chronic Pain
Boston; Brigham and Women's Hospital (BWH)
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Tolerability, Titration Study, to Evaluate the Efficacy and Safety of Perampanel (E2007) in Patients with Post-Herpetic Neuralgia (PHN)
Boston; Brigham and Women's Hospital (BWH)
Clinical Neuropharmacology of Pain following Spinal Cord Injury
Michigan
Saginaw; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Minnesota
Edina; Medical Advanced Pain Specialists
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Missouri
Jefferson City; Capital Comprehensive Cancer Care Clinic
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
St Peters; Midwest Pharmaceutical Research, Inc.
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
St. Louis; A & A Pain Institute
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
St. Louis; Medex Healthcare Research, Inc.
Chronic pain?
Montana
Great Falls; Research Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Nebraska
Omaha; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
New Jersey
Cedar Knolls; Gastroenterology Research Associates, LLC
HORIZON Therapeutics protocol HZ-CA-301: A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 in Subjects Requiring NSAID Treatment
New Mexico
Albuquerque; Lovelace Scientific Resources
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
New York
Bethpage; Biomedical Research Alliance of New York
Chronic Severe Pain
Great Neck; Long Island Gasronintestinal Research Group
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
New York; New York State Psychiatric Institute
Outpatient study for women and men with mild, chronic pain
New York; New York State Psychiatric Institute
Adults (age 18-65) suffering from chronic pain needed for inpatient/outpatient study
Rochester; AAIR Research Center
You may not know some pain medications can cause stomach ulcers.
North Carolina
Boone; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Charlotte; Carolinas Research Associates
A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 in Subjects Requiring NSAID Treatment
College; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Flat Rock; Four Seasons Hospice & Pallative Care
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Greensboro; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Harrisburg; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Harrisburg; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
High Point; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
High Point; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Jacksonville; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Raleigh; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Raleigh; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Winston-Salem; Center for Clinical Research
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Ohio
Canton; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Canton; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Canton; Gabrail Cancer Center
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Canton; Gabrail Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Columbus; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Dayton; Dayton Science Institute
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Dover; Gabrail Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Oklahoma
Norman; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Oklahoma City; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Oklahoma City; Oklahoma Gynecologic Oncology
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Oregon
Eugene; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Eugene; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Medford; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Portland; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Pennsylvania
Duncansville; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Duncansville; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
South Carolina
Anderson; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Greer; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Greer; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Sumter; Office of Billy Clowney
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Tennessee
Chattanooga; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Chattanooga; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Chattanooga; ClinSearch
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Memphis; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Texas
Austin; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Austin; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Austin; Lone Star Oncology
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Bellaire; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Bryan; DiscoveResearch, Inc. Bryan/College Station
Shoulder Pain
San Antonio; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
San Antonio; Radiant Research - San Antonio NE
Chronic Pain Research
San Antonio; Radiant Research - San Antonio NE
Chronic Pain Research
Spring; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Utah
Salt Lake City; Lifetree Clinical Research
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Virginia
Christiansburg; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Fairfax; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Fairfax; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Norfolk; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Richmond; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Washington
Spokane; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
Wisconsin
Milwaukee; Research Center
This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.
Milwaukee; Research Center
This is a 12-month study to provide long-term safety data for subjects at risk for developing NSAID-associated upper gastrointestinal ulcers
